This topic contains a solution. Click here to go to the answer

Author Question: The central nervous system (CNS) consists of: a. The cranial nerves that enter and leave the ... (Read 46 times)

chandani

  • Hero Member
  • *****
  • Posts: 541
The central nervous system (CNS) consists of:
 
  a. The cranial nerves that enter and leave the underside of the brain
  b. The brain and the spinal cord
  c. The spinal cord and the brain stem
  d. All neurons in the body

Question 2

Loss of myelin from neurons would be expected to:
 
  A) Speed up neuronal conduction
  B) Greatly impair neuronal conduction
  C) Increase the amplitude of the action potential
  D) Prevent the removal of dead nerve cells in the brain



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ntsoane kedibone

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

B

Answer to Question 2

B




chandani

  • Member
  • Posts: 541
Reply 2 on: Jun 22, 2018
Great answer, keep it coming :)


deja

  • Member
  • Posts: 332
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library